Abstract
Head and neck cancer is an important cause of ill health with rapidly changing aetiology. Survival appears to have improved but the reasons for this are unclear. Adequately-powered, longitudinal studies in people with head and neck cancer are required. We recruited 5511 people with head and neck cancer to a large DNA-backed clinical cohort. Multi-centre clinical cohort studies in head and neck cancer are feasible in the UK. This article is protected by copyright. All rights reserved.
Original language | English |
---|---|
Journal | Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery |
DOIs | |
Publication status | Published - 5 Oct 2015 |